Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee advances bill to require drug rebate pass-through at point of sale for commercial plans; insurers warn of higher premiums
Summary
Senators advanced HB 14 81, a commercial-insurance-only bill that would require certain drug-manufacturer rebates be passed through at point of sale to reduce patients' coinsurance or deductible costs. Supporters said it would lower out-of-pocket costs for patients with chronic conditions; health-plan and PBM representatives warned it could raise premiums for the broader insured population.
State Senator Justin Boyd (District 27) presented House Bill 14 81 to the Senate Insurance & Commerce Committee, describing the measure as limited to commercial insurance plans and designed to route manufacturer rebates to the pharmacy counter so they reduce a patient's coinsurance or deductible rather than being retained upstream by plans or pharmacy benefit managers (PBMs).
The hearing drew multiple witnesses. Jonathan Buxton of the Pharmaceutical Care Management Association testified in opposition, saying point-of-sale rebate mandates can shift savings away from premiums and raise overall costs. Buxton cited an analysis attributed to the Centers for Medicare & Medicaid…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
